Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

被引:2042
作者
Pappas, Peter G. [1 ]
Kauffman, Carol A. [2 ,3 ]
Andes, David [5 ]
Benjamin, Daniel K., Jr. [6 ]
Calandra, Thierry F. [12 ]
Edwards, John E., Jr. [7 ]
Filler, Scott G. [7 ]
Fisher, John F. [8 ]
Kullberg, Bart-Jan [13 ]
Ostrosky-Zeichner, Luis [9 ]
Reboli, Annette C. [10 ]
Rex, John H. [14 ]
Walsh, Thomas J. [11 ]
Sobel, Jack D. [4 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Ann Arbor Vet Adm Hlth Care Syst, Ann Arbor, MI USA
[4] Wayne State Univ, Detroit, MI USA
[5] Univ Wisconsin, Madison, WI USA
[6] Duke Univ, Med Ctr, Durham, NC USA
[7] Harbor Univ Calif Los Angeles, Med Ctr, Torrance, CA USA
[8] Med Coll Georgia, Augusta, GA 30912 USA
[9] Univ Texas Houston, Houston, TX USA
[10] Univ Med & Dent New Jersey, Cooper Hosp, Camden, NJ 08103 USA
[11] NCI, Bethesda, MD 20892 USA
[12] CHU Vaudois, CH-1011 Lausanne, Switzerland
[13] Univ Nijmegen, Ctr Infect Dis, Nijmegen, Netherlands
[14] Astra Zeneca Pharmaceut, Manchester, Lancs, England
基金
美国国家卫生研究院;
关键词
LIPOSOMAL AMPHOTERICIN-B; INVASIVE FUNGAL-INFECTIONS; PROSTHETIC VALVE ENDOCARDITIS; EMPIRICAL ANTIFUNGAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; LIVER-TRANSPLANT RECIPIENTS; ILL SURGICAL-PATIENTS; INTENSIVE-CARE-UNIT; ITRACONAZOLE ORAL SOLUTION; VULVO-VAGINAL CANDIDIASIS;
D O I
10.1086/596757
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults. This new information is incorporated into this revised document.
引用
收藏
页码:503 / 535
页数:33
相关论文
共 297 条
[51]   Caspofungin for the treatment of less common forms of invasive candidiasis [J].
Cornely, Oliver A. ;
Lasso, Martin ;
Betts, Robert ;
Klimko, Nickolay ;
Vazquez, Jose ;
Dobb, Geoff ;
Velez, Juan ;
Williams-Diaz, Angela ;
Lipka, Joy ;
Taylor, Arlene ;
Sable, Carole ;
Kartsonis, Nicholas .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) :363-369
[52]   Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J].
Cornely, Oliver A. ;
Maertens, Johan ;
Winston, Drew J. ;
Perfect, John ;
Ullmann, Andrew J. ;
Walsh, Thomas J. ;
Helfgott, David ;
Holowiecki, Jerzy ;
Stockelberg, Dick ;
Goh, Yeow-Tee ;
Petrini, Mario ;
Hardalo, Cathy ;
Suresh, Ramachandran ;
Angulo-Gonzalez, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :348-359
[53]   Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults [J].
Courtney, R ;
Pai, S ;
Laughlin, M ;
Lim, J ;
Batra, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) :2788-2795
[54]   LONG-TERM SURVIVAL AFTER FLUCONAZOLE THERAPY OF CANDIDAL PROSTHETIC VALVE ENDOCARDITIS [J].
CZWERWIEC, FS ;
BILSKER, MS ;
KAMERMAN, ML ;
BISNO, AL .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (05) :545-546
[55]   FAILURE OF FLUCONAZOLE THERAPY FOR STERNAL OSTEOMYELITIS DUE TO CANDIDA-ALBICANS [J].
DAN, M ;
PRIEL, I .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) :126-127
[56]   Successful treatment of Candida glabrata endophthalmitis with amphotericin B lipid complex (ABLC) [J].
Darling, K ;
Singh, J ;
Wilks, D .
JOURNAL OF INFECTION, 2000, 40 (01) :92-94
[57]  
de Repentigny L, 1998, ANTIMICROB AGENTS CH, V42, P404
[58]   A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients [J].
de Wet, N ;
Llanos-Cuentas, A ;
Suleiman, J ;
Baraldi, E ;
Krantz, EF ;
Della Negra, M ;
Diekmann-Berndt, H .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) :842-849
[59]   Amphotericin B nephrotoxicity [J].
Deray, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 :37-41
[60]  
Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080